Morphologic and Microscopic Characterization of an Unusual Pancreatic Cystic Lesion.
Stephen A Firkins, Wei Chen, Somashekar G Krishna
https://pubmed.ncbi.nlm.nih.gov/33039474/Actively Recruiting
Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-10-13
500
Participants Needed
10
Research Sites
N/A
Total Duration
Researchers are observing patients with pancreatic cysts to assess the use of confocal laser endomicroscopy nCLE as an imaging biomarker for diagnosis. The study involves patients referred to academic centers for endoscopic ultrasound EUS evaluation of pancreatic cystic lesions PCL who meet specific criteria. The goal is to improve the accuracy of PCL diagnosis and risk stratification, particularly for intraductal papillary mucinous neoplasms IPMNs. Participants undergo EUS-guided nCLE imaging first, followed by EUS-guided fine needle aspiration FNA to collect cyst fluid. The fluid is analyzed for carcinoembryonic antigen CEA, cytology, and molecular markers as part of standard care. Based on multidisciplinary tumor board recommendations, some patients may proceed to surgery, where surgical histopathology acts as the gold standard for diagnosis. During the study, participants are evaluated using these imaging and fluid analysis procedures. Researchers measure the accuracy of diagnosis and risk stratification over 48 months, also assessing imaging quality. The study involves obtaining patient consent and collecting data from procedures and surgical outcomes when applicable, continuing until the study completion date in 2028.
CONDITIONS
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
M
Megan Fry
D
Diana Burke
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ohio State University Comprehensive Cancer Center
Lead Sponsor
American College of Gastroenterology
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies by participant
Participants undergo endoscopic ultrasound with confocal laser endomicroscopy imaging followed by fine needle aspiration to collect cyst fluid. The fluid is analyzed for markers, and diagnosis is evaluated.
1 or more visits depending on clinical need
Duration - Varies by participant
Based on tumor board recommendations, some participants may have surgery. Surgical tissue is analyzed to confirm diagnosis. Follow-up assessments are conducted as needed.
Additional visits as required for surgery and recovery
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Stephen A Firkins, Wei Chen, Somashekar G Krishna
https://pubmed.ncbi.nlm.nih.gov/33039474/Ohio State University Comprehensive Cancer Center
Lead Sponsor
American College of Gastroenterology
Collaborating Sponsor